About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il7rtm1Iku
targeted mutation 1, Koichi Ikuta
MGI:3038693
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il7rtm1Iku/Il7rtm1Iku involves: 129P2/OlaHsd * C57BL/6J MGI:3038733


Genotype
MGI:3038733
hm1
Allelic
Composition
Il7rtm1Iku/Il7rtm1Iku
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il7rtm1Iku mutation (0 available); any Il7r mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• normal natural killer (NK) cell development and function relative to wild-type mice
• 20- to 70-fold reduction in thymus cellularity relative to wild-type mice
• severe impairment of B cell differentiation, with a 10-fold reduction in B220+IgM- (pro-B to pre-B) cells relative to wild-type mice
• tendency of B-cell precursors to be blocked at the HSAloBP-1- fraction, indicating impaired B-cell development form fractions A to B
• analysis of CD4-CD8- thymocytes with CD44 and CD25 markers indicates that the percentage of cells at the Cd44+CD25- stage is increased relative to wild-type mice
• severe block in development of gamma-delta T cells in both thymic and extrathymic pathways
• slight increase in the ratio fo CD4+ to CD8+ T cells relative to wild-type mice
• slight reduction in the number of white blood cells in peripheral blood
• 2-fold reduction in the number of lymphoid cells
• 40-fold decrease in percentage of B220+IgM+ (immature B cells) relative to wild-type mice
• 40-fold decrease in percentage of B220highIgM+ (mature B cells) relative to wild-type mice
• 12- to 45-fold reduction n the number of mature IgM+B220+ B cells in spleen relative to wild-type mice
• reduction in the percentage of peritoneal B-1 (IgM+CD25+) cells relative to wild-type mice
• 5- to 33-fold reduction in the number of mature T cells bearing alpha-beta TCR in spleen relative to wild-type mice
• slight reduction in the percentage of CD4+CD8+ cells; however, thymocyte differentiation is not arrested
• absence of gamma-delta T cells from skin, gut, liver, and spleen
• in contrast, alpha beta T and B cells are still detectable in reduced numbers
• 3- to 12-fold reduction in spleen cellularity relative to wild-type mice
• 12- to 45-fold reduction n the number of mature IgM+B220+ B cells in spleen relative to wild-type mice
• 5- to 33-fold reduction in the number of mature T cells bearing alpha-beta TCR in spleen relative to wild-type mice
• anlages of Peyer's patches do not form

hematopoietic system
• 20- to 70-fold reduction in thymus cellularity relative to wild-type mice
• severe impairment of B cell differentiation, with a 10-fold reduction in B220+IgM- (pro-B to pre-B) cells relative to wild-type mice
• tendency of B-cell precursors to be blocked at the HSAloBP-1- fraction, indicating impaired B-cell development form fractions A to B
• analysis of CD4-CD8- thymocytes with CD44 and CD25 markers indicates that the percentage of cells at the Cd44+CD25- stage is increased relative to wild-type mice
• severe block in development of gamma-delta T cells in both thymic and extrathymic pathways
• slight reduction in bone marrow cellularity
• slight increase in the ratio fo CD4+ to CD8+ T cells relative to wild-type mice
• slight reduction in the number of white blood cells in peripheral blood
• 2-fold reduction in the number of lymphoid cells
• 40-fold decrease in percentage of B220+IgM+ (immature B cells) relative to wild-type mice
• 40-fold decrease in percentage of B220highIgM+ (mature B cells) relative to wild-type mice
• 12- to 45-fold reduction n the number of mature IgM+B220+ B cells in spleen relative to wild-type mice
• reduction in the percentage of peritoneal B-1 (IgM+CD25+) cells relative to wild-type mice
• 5- to 33-fold reduction in the number of mature T cells bearing alpha-beta TCR in spleen relative to wild-type mice
• slight reduction in the percentage of CD4+CD8+ cells; however, thymocyte differentiation is not arrested
• absence of gamma-delta T cells from skin, gut, liver, and spleen
• in contrast, alpha beta T and B cells are still detectable in reduced numbers
• 3- to 12-fold reduction in spleen cellularity relative to wild-type mice
• 12- to 45-fold reduction n the number of mature IgM+B220+ B cells in spleen relative to wild-type mice
• 5- to 33-fold reduction in the number of mature T cells bearing alpha-beta TCR in spleen relative to wild-type mice

endocrine/exocrine glands
• 20- to 70-fold reduction in thymus cellularity relative to wild-type mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory